Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2023 - 2026)

Taysha Gene Therapies (TSHA) has 4 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 79.45% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (down 79.45% YoY), and the FY2025 full-year result was 0.02, down 56.35% from the prior year.
• Asset Utilization Ratio declined to 0.01 in Q1 2026, from 0.02 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q1 2024 to a low of 0.01 in Q1 2026.
• A 4-year average of 0.05 and a median of 0.05 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio sank 41.65% in 2024 and sank 79.45% in 2026, its largest moves.
• Tracing TSHA's Asset Utilization Ratio over 4 years: stood at 0.08 in 2023, then plunged by 41.65% to 0.05 in 2024, then tumbled by 65.93% to 0.02 in 2025, then sank by 40.39% to 0.01 in 2026.
• Business Quant data shows TSHA's Asset Utilization Ratio at 0.01 in Q1 2026, 0.02 in Q4 2025, and 0.02 in Q3 2025.